3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
13
Unknown
1
Terminated
1
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Sarcoma
7
Lymphoma, Large B-Cell, Diffuse
6
Osteosarcoma
3
Lymphoma, B-Cell
3
Sarcoma, Ewing
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Penile Neoplasms
2
Neurofibrosarcoma
2
Liposarcoma
2
Hemangiosarcoma
2
Fibrosarcoma
2
Burkitt Lymphoma
2
Wilms Tumor
1
Vascular Neoplasms
1
Teratoma
1
Solitary Fibrous Tumors
1
Smooth Muscle Tumor
1
Sarcoma, Synovial
1
Sarcoma, Endometrial Stromal
1
Sarcoma, Clear Cell
1
Rhabdomyosarcoma
1
Recurrence
1
Prostatic Neoplasms
1
Pleuropulmonary blastoma
1
Neuroblastoma
1
Nerve Sheath Neoplasms
1
Neoplasms, Adipose Tissue
1
Neoplasm Metastasis
1
Myoepithelioma
1
Lymphoma, T-Cell, Peripheral
1
Interventions
Cyclophosphamide
20
Rituximab
18
obinutuzumab
14
Lenalidomide
14
zanubrutinib
11
fludarabine
10
Bendamustine Hydrochloride
10
Prednisone
8
Magnetic Resonance Spectroscopy
8
Vincristine
7
Doxorubicin
7
Specimen Handling
6
fludarabine phosphate
5
Radiotherapy
4
Biopsy
4
axicabtagene ciloleucel
3
Whole-Body Irradiation
3
tisagenlecleucel
2
polatuzumab vedotin
2
pirtobrutinib
2
loncastuximab tesirine
2
Therapeutics
2
Prednisolone
2
Positron Emission Tomography Computed Tomography
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Leukapheresis
2
Immunotherapy, Adoptive
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Lymphoma, Follicular
×
Ifosfamide
×
Clear all
NCT02393157
2025-08-08
O-ICE
New York Medical College
Phase 2
Recruiting
25 enrolled